Skip to main content
Premium Trial:

Request an Annual Quote

Canada Provides C$1.1M for Synthetic Biology to University of Lethbridge

NEW YORK (GenomeWeb) – The Canadian government today announced it is providing C$1.1 million (US$864,000) in funding to the University of Lethbridge to support the creation of Alberta's first synthetic biology maker space. 

With the funding provided through Western Economic Diversification Canada's Western Diversification Program, the synthetic biology maker space will "enhance research capabilities, boost services available for industry partners, increase training capacity … and enable students to explore commercial applications of their research ideas," WEDC said in a statement. 

The funding will go toward the purchase of a PCR cycler and a cell sorter, as well as the development of a protein and nucleic acid purification infrastructure for assembling biological devices.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.